Concepedia

The Parity Paradigm: Can Legislation Help Reduce the Cost Burden of Oral Anticancer Medications?

Sheetal Kircher, Caitlin R. Meeker, Halla Nimeiri, Daniel M. Geynisman, S. Yousuf Zafar, Veena Shankaran, Jonas de Souza, Yu-Ning Wong

Value in Health · 2015 · 29 citations · 20 references

DOI

Concepts

References

20

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

Brian Druker, Moshe Talpaz, Debra Resta et al. · New England Journal of Medicine · 2001 · 5.2K citations · Full text

, , +12

The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience

S. Yousuf Zafar, Jeffrey Peppercorn, Deborah Schrag et al. · The Oncologist · 2013 · 1.1K citations · Full text

, , +16

Oral Capecitabine Compared With Intravenous Fluorouracil Plus Leucovorin in Patients With Metastatic Colorectal Cancer: Results of a Large Phase III Study

Eric Van Cutsem, Chris Twelves, Jim Cassidy et al. · Journal of Clinical Oncology · 2001 · 1K citations

, , +14

Patient preferences for oral versus intravenous palliative chemotherapy.

Geoffrey Liu, E. Franssen, Margaret I. Fitch et al. · Journal of Clinical Oncology · 1997 · 920 citations

, , +14

Financial toxicity, Part I: a new name for a growing problem.

S. Yousuf Zafar, Amy P. Abernethy · PubMed · 2013 · 500 citations

, , +17